Feasibility and Acceptability of Using Wireless Cardiac Monitoring Before Transcatheter Aortic Valve Implantation (TAVI): A Pilot Study.

Abstract

Currently, all transcatheter aortic valve implantation (TAVI) patients treated at Epworth Richmond are admitted the day before their procedure for cardiac monitoring to identify undiagnosed arrhythmias that may increase the risk of requiring a permanent pacemaker. These patients also undergo routine pre-operative investigations, including full blood tests, a chest X-ray and an ECG. Use of remote cardiac monitoring devices from the patient’s home may improve workflow efficiency, reduce bed usage in the coronary care unit and increase overall bed capacity. This may ultimately lead to increased hospital revenue. However, the use of such devices has not been adequately tested.